Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis
Vascular Pharmacology · 2024-06 · 155 · 107368
DOI: 10.1016/j.vph.2024.107368 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vascular Pharmacology, 2024-06. Verfasst von Bandana Singh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Program, Department of Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Atherosclerosis, Autophagy, Endothelial Cells, Signal Transduction. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, BLRD VA, National Institutes of Health.
Abstract (Originalsprache)
Atherosclerosis, a chronic systemic inflammatory condition, is implicated in most cardiovascular ischemic events. The pathophysiology of atherosclerosis involves various cell types and associated processes, including endothelial cell activation, monocyte recruitment, smooth muscle cell migration, involvement of macrophages and foam cells, and instability of the extracellular matrix. The process of endothelial-to-mesenchymal transition (EndoMT) has recently emerged as a pivotal process in mediating vascular inflammation associated with atherosclerosis. This transition occurs gradually, with a significant portion of endothelial cells adopting an intermediate state, characterized by a partial loss of endothelial-specific gene expression and the acquisition of "mesenchymal" traits. Consequently, this shift disrupts endothelial cell junctions, increases vascular permeability, and exacerbates inflammation, creating a self-perpetuating cycle that drives atherosclerotic progression. While endothelial cell dysfunction initiates the development of atherosclerosis, autophagy, a cellular catabolic process designed to safeguard cells by recycling intracellular molecules, is believed to exert a significant role in plaque development. Identifying the pathological mechanisms and molecular mediators of EndoMT underpinning endothelial autophagy, may be of clinical relevance. Here, we offer new insights into the underlying biology of atherosclerosis and present potential molecular mechanisms of atherosclerotic resistance and highlight potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vascular Biology Program, Department of Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
- Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA.
- Center for Regenerative Medicine, University of South Florida Health Heart Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
- Division of Cardiovascular Medicine, Department of Medicine, University of Missouri School of Medicine, Columbia, MO, USA.
- Vascular Biology Program, Department of Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA. Electronic address: hong.chen@childrens.harvard.edu.
Förderung
- NHLBI NIH HHS
- BLRD VA
- National Institutes of Health
- American Heart Association
Zitieren
APA
Singh, B., Cui, K., Eisa-Beygi, S., Zhu, B., Cowan, D. B., Shi, J., Wang, D. Z., Liu, Z., Bischoff, J., & Chen, H. (2024). Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis. Vascular Pharmacology, 155, 107368. https://doi.org/10.1016/j.vph.2024.107368
Vancouver
Singh B, Cui K, Eisa-Beygi S, Zhu B, Cowan DB, Shi J, et al. Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis. Vascular Pharmacology. 2024;155:107368. doi:10.1016/j.vph.2024.107368
BibTeX
@article{Singh2024,
author = {Singh, Bandana and Cui, Kui and Eisa-Beygi, Shahram and Zhu, Bo and Cowan, Douglas B and Shi, Jinjun and Wang, Da-Zhi and Liu, Zhenguo and Bischoff, Joyce and Chen, Hong},
title = {Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis},
journal = {Vascular Pharmacology},
year = {2024},
volume = {155},
pages = {107368},
doi = {10.1016/j.vph.2024.107368}
}
EUVIMED